Karim Chamie

发表

Letters to the Editor/Errata Re: Improved Prediction of Long-Term, Other Cause Mortality in Men With Prostate Cancer

Mark S. Litwin, Sheldon Greenfield, Timothy J. Daskivich, 2012 .

Improved prediction of long-term, other cause mortality in men with prostate cancer.

Sheldon Greenfield, Mark S Litwin, Karim Chamie, 2011, The Journal of urology.

Comorbidity and competing risks for mortality in men with prostate cancer

Sheldon Greenfield, Mark S Litwin, Karim Chamie, 2011, Cancer.

Impact of treatment on progression to castration‐resistance, metastases, and death in men with localized high‐grade prostate cancer

Isla P. Garraway, Beatrice S. Knudsen, Karim Chamie, 2016, Cancer medicine.

Quality of care in patients with bladder cancer

Claude M Setodji, Badrinath R Konety, Christopher S Saigal, 2012, Cancer.

Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice

Susan Airhart, Ralph de Vere White, Karim Chamie, 2016, Molecular Cancer Therapeutics.

Recurrence of high‐risk bladder cancer: A population‐based analysis

Karim Chamie, T. Daskivich, M. Litwin, 2013, Cancer.

The role of magnetic resonance imaging in delineating clinically significant prostate cancer.

Shyam Natarajan, Steven S Raman, Jiaoti Huang, 2014, Urology.

Development and Validation of an Automated Method to Identify Patients Undergoing Radical Cystectomy for Bladder Cancer Using Natural Language Processing

Mark S. Litwin, Karim Chamie, M. Litwin, 2017 .